Mermaid Medical Group® and MicroPort® Announce Exclusive Distribution Agreement for TAVI and LAAC Devices

Copenhagen, Denmark, July 2025 

Mermaid Medical Group® will be introducing VitaFlow Liberty™ and Anchorman™ to Denmark, Norway, Sweden, Finland, and Iceland, further strengthening both companies’ presence in the Nordic region.

VitaFlow Liberty is used in TAVI (Transcatheter Aortic Valve Implantation) procedures to treat severe aortic stenosis, a condition where the heart’s aortic valve narrows and restricts blood flow. VitaFlow Liberty is used to replace the faulty heart valve through a minimally invasive catheter-based procedure, avoiding open-heart surgery. It features the world’s first motorized delivery system, allowing precise, controlled placement with the ability to recapture and reposition the valve during deployment for optimal results.

Anchorman is designed for LAAC (Left Atrial Appendage Closure) procedures to reduce stroke risk in patients with atrial fibrillation, a condition characterized by irregular heartbeats in the upper chambers of the heart. Delivered via catheter, the Anchorman device is placed at the opening of the left atrial appendage to seal it off, preventing blood from pooling and clot formation that could lead to stroke.

MicroPort operates globally through multiple subsidiaries across a broad range of medical specialties, and is dedicated to ensuring that patients everywhere can enjoy better and longer lives through innovative solutions. This collaboration represents a significant step forward for Mermaid Medical Group in strengthening its presence in the cardiovascular field. The appointment of Maria Isabell Gustavsen as Business Unit Manager for Interventional Cardiology underscores this commitment and marks the beginning of a more dedicated focus within this area.

“Our collaboration with MicroPort opens exciting opportunities in interventional cardiology and strengthens our ability to deliver innovative cardiovascular solutions to the Nordic market. I’m excited to help shape this journey, as bringing these advanced technologies to patients marks an important step toward improving patient care and procedural outcomes.”
- Maria Isabell Gustavsen, Business Unit Manager, Interventional Cardiology

About MicroPort®
MicroPort is a global medical technology company with a diverse portfolio that includes cardiovascular, orthopedics, neurology, and other medical fields. The company develops and manufactures a wide range of medical devices aimed at improving patient care. With operations spanning Asia, Europe, and the Americas, MicroPort works closely with healthcare professionals to provide effective solutions that address various clinical needs.

About Mermaid Medical Group®
Mermaid Medical Group is a privately owned global medical technology company dedicated to delivering high-quality, innovative solutions to healthcare professionals worldwide. The company develops, manufactures, and distributes a diverse portfolio of medical devices, primarily focusing on solutions for diseases of the vascular system and devices used in interventional radiology, oncology, and cardiology. With a reach that spans Europe, the U.S., and Asia, Mermaid Medical Group is committed to advancing patient care and improving clinical outcomes globally.

Media Contact:
Anne Sandgaard
Mermaid Medical Group
+45 2194 8508 
asa@mermaidmedical.com